Physician profile
David Bloom
NPI 1417261785
$1,598.89
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $310 · 2022: $226 · 2023: $121 · 2024: $147 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $326.41 | 2019-2020 | |
| Medline Industries Lp | $268.57 | 2019-2020 | |
| Allergan, INC. | $194.55 | 2020 | |
| Stryker Corporation | $158.31 | 2023-2025 | Mako, Gamma |
| Zimmer Biomet Holdings, INC. | $146.72 | 2024 | Persona |
| Aimmune Therapeutics, INC. | $125.00 | 2025 | Zenpep |
| Shionogi INC | $122.45 | 2022 | |
| Baxter Healthcare | $103.26 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $86.79 | 2019 | |
| Convatec INC. | $34.22 | 2019 | |
| Organogenesis INC. | $19.53 | 2019 | |
| Aroa Biosurgery Incorporated | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.